Laura M Kulik

Active

Prot#MGL-3196-18: A 52-Week, Phase 3 Open-Label Extension Study, with a Single-blind Lead-in, to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients with Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAEST

Cheung, A.C.-W. (PD/PI), Flamm, S. L. (PD/PI), Kulik, L. M. (PD/PI) & Rinella, M. E. (PD/PI)

Pharmaceutical Research Associates, Inc., Synta Pharmaceuticals Corp.

2/16/22 → 2/16/25

Project: Research project

Natural history, risk prediction and cost of cirrhosis in insured Americans.

Ladner, D. P. (PD/PI), Ladner, D. P. (PD/PI), Manski, C. (PD/PI), Manski, C. (PD/PI), Ackermann, R. T. (Co-Investigator), Ackermann, R. T. (Co-Investigator), Balbale, S. N. (Co-Investigator), Dietch, Z. C. (Co-Investigator), Dietch, Z. C. (Co-Investigator), Dietch, Z. C. (Co-Investigator), Duarte, A. (Co-Investigator), Duarte, A. (Co-Investigator), Kulik, L. M. (Co-Investigator), Kulik, L. M. (Co-Investigator), Levitsky, J. (Co-Investigator), Levitsky, J. (Co-Investigator), VanWagner, L. B. (Co-Investigator), Zhao, L. (Co-Investigator) & Zhao, L. (Co-Investigator)

National Institute of Diabetes and Digestive and Kidney Diseases

2/1/22 → 1/31/26

Project: Research project

Yittrium-90 radiation lobectomy: Dose optimization and prediction of FLR hypertrophy to enable resection of HCC

Collins, J. D. (PD/PI), Collins, J. D. (PD/PI), Lewandowski, R. J. (PD/PI), Lewandowski, R. J. (PD/PI), Caicedo, J. C. (Co-Investigator), Caicedo, J. C. (Co-Investigator), Collins, J. D. (Co-Investigator), Katariya, N. N. (Co-Investigator), Katariya, N. N. (Co-Investigator), Kulik, L. M. (Co-Investigator), Kulik, L. M. (Co-Investigator), Markl, M. (Co-Investigator), Markl, M. (Co-Investigator), Miller, F. H. (Co-Investigator), Miller, F. H. (Co-Investigator), Pezhouh, M. K. (Co-Investigator), Pezhouh, M. K. (Co-Investigator), Ragin, A. (Co-Investigator) & Ragin, A. (Co-Investigator)

National Cancer Institute

8/1/19 → 7/31/26

Project: Research project

Finished

Noninvasive Assessment of Esophageal Varices in Patients with Unresectable Hepatocellular Carcinoma

Kulik, L. M. (PD/PI)

University of Michigan, Genentech, Inc

3/4/21 → 10/31/22

Project: Research project

Prot#G-1001: Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma

Kulik, L. M. (PD/PI)

Glycotest, Inc.

7/1/19 → 12/31/23

Project: Research project

NU 18I03 - Pilot Study of Nivolumab in Combination with Therasphere (yttrium-90) for Treatment of Hepatocellular Carcinoma (HCC) with Intent for Resection

Kulik, L. M. (PD/PI)

Bristol-Myers Squibb Company

1/8/19 → 1/8/22

Project: Research project

REFINE: Regorafenib Observational Study in Hepatocellular Carcinoma

Kulik, L. M. (PD/PI)

Quintiles, Inc., Bayer HealthCare Pharmaceuticals, Inc.

10/25/18 → 10/25/21

Project: Research project

A 5-year Longitudinal Observational Study of the Natural History and Management of Patients with Hepatocellular Carcinoma

Kulik, L. M. (PD/PI)

TARGET PharmaSolutions, Inc.

6/28/18 → 7/24/24

Project: Research project

Statin Intervention to Slow the Time to Hepatocellular Carcinoma Recurrence in Cirrhotics Awaiting Liver Transplantation

Kulik, L. M. (PD/PI)

Cedars-Sinai Medical Center, National Cancer Institute

7/6/17 → 5/31/22

Project: Research project

Biomarker Analyses in Hepatocellular Carcinoma Patients Treated with TheraSphere®

Riaz, A. (PD/PI), Kulik, L. M. (Co-PD/PI) & Salem, R. (Co-PD/PI)

Biocompatibles UK Ltd.

2/15/17 → 2/15/20

Project: Research project

Prot #M14-726: Open-label Study to Evaluate the Safety and Efficacy of the Combination of Ombitasvir, Paritaprevir/r ± Dasabuvir with Ribavirin (RBV) in Adult Patients with GT1 or GT4 Chronic HCV Infection and Response to Prior Treatment of Early Stage He

Kulik, L. M. (PD/PI)

AbbVie Inc.

11/10/15 → 11/10/18

Project: Research project

Prot #HCCBAYLOR12: A 36-Month Multi-Center, Open Label, Randomized, Comparator Study to Evaluate the Efficacy and Safety of Everolimus Immunosuppression Treatment in Liver Transplantation for Hepatocellular Carcinoma Exceeding Milan Criteria

Baker, T. B. (PD/PI) & Kulik, L. M. (PD/PI)

Baylor Research Institute, Novartis Pharmaceuticals Corporation

8/11/14 → 3/31/22

Project: Research project

Prot # ROF-NASH_205: A Randomized, Double-Blind, Controlled, Multi-Center Phase 2 Study to Evaluate the Effect of Roflumilast Plus Pioglitazone on Liver Enzymes and Liver Fat Content in Subjects with Nonalcoholic Steatohepatitis

Rinella, M. E. (PD/PI), Ganger, D. R. (Co-PD/PI), Green, R. (Co-PD/PI), Koppe, S. W. P. (Co-PD/PI) & Kulik, L. M. (Co-PD/PI)

Quintiles, Inc., Takeda Development Center Americas, Inc.

2/11/14 → 2/11/17

Project: Research project

A Multi-Center, Randomized, Prospective, Open-Label Phase III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Hepatitis C Immune Globulin Intravenous (Human), Civacir®, in Orthotopic Liver Transplant Recipients

Kulik, L. M. (PD/PI)

Covance Inc., Biotest Pharmaceuticals Corporation

1/16/14 → 1/16/16

Project: Research project

DRUG TS-104: A prospective randomized clinical trial on 90Yttrium trans-arterial radio-Embolization (TheraSphere®) vs. Sorafenib for the treatment of advanced Hepatocellular Carcinoma (HCC) with Portal Vein Thrombosis (PVT)

Kulik, L. M. (PD/PI)

Theorem Clinical Research, Biocompatibles UK Ltd.

6/5/13 → 6/5/16

Project: Research project

Prot # ONC-2010-31: A Phase II Randomized Multicenter Placebo-Controlled Blinded Study of Sorafenib Adjuvant Therapy in High Risk Orthotopic Liver Transplant (OLT) Recipients with Hepatocellular Carcinoma (HCC)

Kulik, L. M. (PD/PI)

University of California, Los Angeles, Bayer HealthCare Pharmaceuticals, Inc.

8/1/12 → 9/30/17

Project: Research project

Prot # TS-103: A Phase III Clinical Trial of Intra-arterial TheraSphere in the Treatment of Patients with Unresectable Hepatocelluar Carcinoma(HCC)

Kulik, L. M. (PD/PI)

Theorem Clinical Research, Nordion (Canada) Inc.

3/28/12 → 9/30/23

Project: Research project

ACRIN 6690: A Prospective, Multi-Center Comparison of Multiphase Contrast-Enhanced CT and Multiphase Contrast Enhanced MRI for Diagnosis of Hepatocellular Carcinoma and Liver Transplant Allocation

Baker, T. B. (PD/PI), Hammond, N. A. (Co-PD/PI), Kulik, L. M. (Co-PD/PI) & Miller, F. H. (Co-PD/PI)

American College of Radiology Imaging Network, National Cancer Institute

8/1/11 → 12/31/11

Project: Research project

Prot # VTR 10-03: The GORE® VIATORR® TIPS Endoprosthesis versus Large-Volume Paracentesis for the Treatment of Ascites in Patients with Portal Hypertension(Early TIPS for Ascites Study)

Rinella, M. E. (PD/PI), Flamm, S. L. (Co-Investigator), Ganger, D. R. (Co-Investigator), Green, R. (Co-Investigator), Koppe, S. W. P. (Co-Investigator), Kulik, L. M. (Co-Investigator) & Levitsky, J. (Co-Investigator)

W. L. Gore and Associates

4/19/11 → 3/1/13

Project: Research project

Living Donor Liver Transplant - Predictive Models for Long-Term Health Outcomes

Abecassis, M. M. (PD/PI), Baker, T. B. (Co-PD/PI), Butt, Z. (Co-PD/PI), Kulik, L. M. (Co-PD/PI), Ladner, D. P. (Co-PD/PI), Skaro, A. I. (Co-PD/PI) & Woods, D. (Co-PD/PI)

National Institute of Diabetes and Digestive and Kidney Diseases

9/30/10 → 8/31/11

Project: Research project

Living Donor Liver Transplant - Predictive Models for Long-Term Health Outcomes

Abecassis, M. M. (PD/PI), Baker, T. B. (Co-Investigator), Butt, Z. (Co-Investigator), Gordon, E. (Co-Investigator), Kulik, L. M. (Co-Investigator), Ladner, D. P. (Co-Investigator) & Woods, D. (Co-Investigator)

National Institute of Diabetes and Digestive and Kidney Diseases

9/30/09 → 8/31/15

Project: Research project